Coronavirus Update: No Mortality Gains From Remdesivir In WHO Trial, Gilead Questions Results

Trial Involved 11,000 Patients

 
• By Scrip Team
WHO
The SOLIDARITY trial results have been praised by academic researcher leaders, but questioned by Gilead.

More from Business

More from Scrip